USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/19905
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShendra, Y.-
dc.contributor.authorRutkovska, I.-
dc.contributor.authorYarovka, O.-
dc.date.accessioned2022-02-02T10:33:48Z-
dc.date.available2022-02-02T10:33:48Z-
dc.date.issued2012-
dc.identifier.citationSHENDRA, Y., RUTKOVSKA, I., YAROVKA, O. Medical correction of terminal uveal glaucoma. In: MedEspera: the 4th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2012, p. 162.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/19905-
dc.description.abstractIntroduction: Terminal painful no compensated glaucoma of uveal genesis often requires retrobulbar blockade with ethyl alcohol or, in case of ineffective treatment, enucleation of the eyeball. Objective: To work out medical therapy of terminal uveal glaucoma. Materials and methods: 11 patients with uveal painful terminal glaucoma have been under our observation. We succeeded in elimination of the painful syndrome and in saving of the eyeball, exclusively, by means of medical treatment. The age of patients was from 54 to 65, 7 women and 4 men. The patients were afflicted with unilateral terminal painful uveal glaucoma. Sharpness of eyesight on the eyes was 0 (zero). Before treatment intraocular pressure (IOP) was 47±4.3 mm t/g. Routine ophthalmological examinations including USD of both eyes were performed. The patients received the following medical preparations: cycloplegic drugs (atropine 1/three times a day); topical corticosteroids (dexametasone 0.1 four time); topical (3-blokers (thymol 0.5% twice a day); on the background of general anti-inflammatory therapy. Results: After conducted therapy painful syndrome was arrested, IOP reduced tS 28 ±2.6 mm tig (p<0.05). The patients got recommendations to drop cycloplegic drugs corticosteroids and (3-blockers after discharge from the hospital constantly. Further examination 6 months later demonstrated stability of the results obtained. The eyes were quiet; pains were absent, IOP-within the norm up to subcompensated level (27±1.9 mm tig). There were no indications for surgery. Conclusions: In case of painful terminal uveal glaucoma the introduced complex of anti-inflammatory and hypotensive therapy results in organ-saving effect. The above mentioned therapy is advisable to use in case of pain of any genesis in a blind eye (except oncopathology), which will likely exclude enucleation.en_US
dc.language.isoenen_US
dc.publisherState Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association, Scientific Association of Students and Young Doctorsen_US
dc.relation.ispartofMedEspera: The 4th International Medical Congress for Students and Young Doctors, May 17-19, 2012, Chisinau, Republic of Moldovaen_US
dc.subjectuveal painful terminal glaucomaen_US
dc.subjectmedical therapyen_US
dc.titleMedical correction of terminal uveal glaucomaen_US
dc.typeOtheren_US
Appears in Collections:MedEspera 2012

Files in This Item:
File Description SizeFormat 
MEDICAL_CORRECTION_OF_TERMINAL_UVEAL_GLAUCOMA.pdf712.4 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback